Company Filing History:
Years Active: 1996-1999
Title: Susan E. Fantini: Innovator in Biosynthetic Pathways
Introduction
Susan E. Fantini is a notable inventor based in Ridgewood, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of biosynthetic pathways. With a total of 2 patents, her work has advanced the understanding and application of nucleic acid molecules.
Latest Patents
Among her latest patents, one focuses on the cloning of the biosynthetic pathway for chlortetracycline. This invention describes a purified and isolated nucleic acid molecule that encodes for the biosynthetic pathway of tetracycline, chlortetracycline, or an analogue thereof. The invention relates to the isolation and cloning of the nucleic acid molecule in an isolated fragment from Streptomyces aureofaciens and the expression of the biosynthetic gene in a heterologous host such as Streptomyces lividans.
Career Highlights
Susan is currently associated with American Cyanamid Company, where she continues to innovate and contribute to her field. Her work has been instrumental in advancing biotechnological applications that have far-reaching implications.
Collaborations
Throughout her career, Susan has collaborated with notable colleagues, including Michael J. Ryan and Jason Arnold Lotvin. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Susan E. Fantini's contributions to the field of biotechnology, particularly through her patents, highlight her role as an innovator in biosynthetic pathways. Her work continues to influence the scientific community and pave the way for future advancements.